225 related articles for article (PubMed ID: 11414762)
1. Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone.
Argiro L; Desbarats M; Glorieux FH; Ecarot B
Genomics; 2001 Jun; 74(3):342-51. PubMed ID: 11414762
[TBL] [Abstract][Full Text] [Related]
2. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia.
Rowe PS; de Zoysa PA; Dong R; Wang HR; White KE; Econs MJ; Oudet CL
Genomics; 2000 Jul; 67(1):54-68. PubMed ID: 10945470
[TBL] [Abstract][Full Text] [Related]
3. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
Quarles LD
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
[TBL] [Abstract][Full Text] [Related]
4. Evidence of downregulation of matrix extracellular phosphoglycoprotein during terminal differentiation in human osteoblasts.
Siggelkow H; Schmidt E; Hennies B; Hüfner M
Bone; 2004 Aug; 35(2):570-6. PubMed ID: 15268910
[TBL] [Abstract][Full Text] [Related]
5. Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone.
Nampei A; Hashimoto J; Hayashida K; Tsuboi H; Shi K; Tsuji I; Miyashita H; Yamada T; Matsukawa N; Matsumoto M; Morimoto S; Ogihara T; Ochi T; Yoshikawa H
J Bone Miner Metab; 2004; 22(3):176-84. PubMed ID: 15108058
[TBL] [Abstract][Full Text] [Related]
6. MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM.
Addison WN; Nakano Y; Loisel T; Crine P; McKee MD
J Bone Miner Res; 2008 Oct; 23(10):1638-49. PubMed ID: 18597632
[TBL] [Abstract][Full Text] [Related]
7. A novel Phex mutation in a new mouse model of hypophosphatemic rickets.
Owen C; Chen F; Flenniken AM; Osborne LR; Ichikawa S; Adamson SL; Rossant J; Aubin JE
J Cell Biochem; 2012 Jul; 113(7):2432-41. PubMed ID: 22573557
[TBL] [Abstract][Full Text] [Related]
8. cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone.
Du L; Desbarats M; Viel J; Glorieux FH; Cawthorn C; Ecarot B
Genomics; 1996 Aug; 36(1):22-8. PubMed ID: 8812412
[TBL] [Abstract][Full Text] [Related]
9. Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers.
Ruchon AF; Tenenhouse HS; Marcinkiewicz M; Siegfried G; Aubin JE; DesGroseillers L; Crine P; Boileau G
J Bone Miner Res; 2000 Aug; 15(8):1440-50. PubMed ID: 10934642
[TBL] [Abstract][Full Text] [Related]
10. Pex/PEX tissue distribution and evidence for a deletion in the 3' region of the Pex gene in X-linked hypophosphatemic mice.
Beck L; Soumounou Y; Martel J; Krishnamurthy G; Gauthier C; Goodyer CG; Tenenhouse HS
J Clin Invest; 1997 Mar; 99(6):1200-9. PubMed ID: 9077527
[TBL] [Abstract][Full Text] [Related]
11. Bone as a source of FGF23: regulation by phosphate?
Mirams M; Robinson BG; Mason RS; Nelson AE
Bone; 2004 Nov; 35(5):1192-9. PubMed ID: 15542045
[TBL] [Abstract][Full Text] [Related]
12. MEPE has the properties of an osteoblastic phosphatonin and minhibin.
Rowe PS; Kumagai Y; Gutierrez G; Garrett IR; Blacher R; Rosen D; Cundy J; Navvab S; Chen D; Drezner MK; Quarles LD; Mundy GR
Bone; 2004 Feb; 34(2):303-19. PubMed ID: 14962809
[TBL] [Abstract][Full Text] [Related]
13. The wrickkened pathways of FGF23, MEPE and PHEX.
Rowe PS
Crit Rev Oral Biol Med; 2004 Sep; 15(5):264-81. PubMed ID: 15470265
[TBL] [Abstract][Full Text] [Related]
14. Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia.
Liu S; Brown TA; Zhou J; Xiao ZS; Awad H; Guilak F; Quarles LD
J Am Soc Nephrol; 2005 Jun; 16(6):1645-53. PubMed ID: 15843468
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of osteoblast Phex expression by PTH.
Alos N; Ecarot B
Bone; 2005 Oct; 37(4):589-98. PubMed ID: 16084134
[TBL] [Abstract][Full Text] [Related]
16. Cloning and sequencing of human PEX from a bone cDNA library: evidence for its developmental stage-specific regulation in osteoblasts.
Guo R; Quarles LD
J Bone Miner Res; 1997 Jul; 12(7):1009-17. PubMed ID: 9199999
[TBL] [Abstract][Full Text] [Related]
17. Regulation of mRNA expression of matrix extracellular phosphoglycoprotein (MEPE)/ osteoblast/osteocyte factor 45 (OF45) by fibroblast growth factor 2 in cultures of rat bone marrow-derived osteoblastic cells.
Zhang GX; Mizuno M; Tsuji K; Tamura M
Endocrine; 2004 Jun; 24(1):15-24. PubMed ID: 15249699
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia.
Barros NM; Hoac B; Neves RL; Addison WN; Assis DM; Murshed M; Carmona AK; McKee MD
J Bone Miner Res; 2013 Mar; 28(3):688-99. PubMed ID: 22991293
[TBL] [Abstract][Full Text] [Related]
19. Increased cathepsin D release by Hyp mouse osteoblast cells.
Matsumoto N; Jo OD; Shih RN; Brochmann EJ; Murray SS; Hong V; Yanagawa J; Yanagawa N
Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E123-32. PubMed ID: 15958652
[TBL] [Abstract][Full Text] [Related]
20. A fragment of the hypophosphatemic factor, MEPE, requires inducible cyclooxygenase-2 to exert potent anabolic effects on normal human marrow osteoblast precursors.
Nagel DE; Khosla S; Sanyal A; Rosen DM; Kumagai Y; Riggs BL
J Cell Biochem; 2004 Dec; 93(6):1107-14. PubMed ID: 15449321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
